​

Funding Round

Series A - Regenacy Pharmaceuticals

Series A - Regenacy Pharmaceuticals

Investment Firm

Overview

Regenacy Pharmaceuticals Provides Healthcare Services.

Announced Date

Mar 25, 2020

Closed on Date

Mar 26, 2020

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Taiwania Capital Management Corporation

Taiwania Capital Management Corporation

Taiwania Capital Management Corporation is a early_stage_venture and late_stage_venture and seed and venture firm.

Cobro Ventures

Cobro Ventures

Cobro Ventures is a early_stage_venture and seed firm.

Participant Investors

6

Investor Name
Participant InvestorRivas Capital
Participant InvestorCobro Ventures
Participant InvestorYonjin Venture
Participant Investor3E Bioventures
Participant InvestorTaiwania Capital Management Corporation

Round Details and Background

Regenacy Pharmaceuticals raised an undisclosed amount on 2020-03-25 in Series A

Regenacy Pharmaceuticals Provides Healthcare Services.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 25, 2020
Series A - Regenacy Pharmaceuticals
7-undefined
Feb 09, 2022
Series B - Regenacy Pharmaceuticals
-7.8M
Aug 15, 2022
Series B - Regenacy Pharmaceuticals
4-9.3M

Recent Activity

There is no recent news or activity for this profile.